GPP
VIRX
Great Point Partners’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-317,962
| Closed | -$132K | – | 46 |
|
|
2018
Q4 | $132K | Sell |
317,962
-682,038
| -68% | -$283K | 0.02% | 33 |
|
|
2018
Q3 | $2M | Buy |
+1,000,000
| New | +$2M | 0.31% | 25 |
|
|
2017
Q4 | – | Sell |
-1,457,712
| Closed | -$2.83M | – | 44 |
|
|
2017
Q3 | $2.83M | Buy |
1,457,712
+26,563
| +2% | +$51.5K | 0.55% | 26 |
|
|
2017
Q2 | $3.86M | Sell |
1,431,149
-106,724
| -7% | -$288K | 0.69% | 26 |
|
|
2017
Q1 | $6.31M | Hold |
1,537,873
| – | – | 1.25% | 21 |
|
|
2016
Q4 | $5.57M | Buy |
1,537,873
+474,300
| +45% | +$1.72M | 1.14% | 21 |
|
|
2016
Q3 | $4.65M | Sell |
1,063,573
-7,110,364
| -87% | -$31.1M | 1.19% | 19 |
|
|
2016
Q2 | $4.48M | Sell |
8,173,937
-76,063
| -0.9% | -$41.7K | 1.28% | 19 |
|
|
2016
Q1 | $4.46M | Hold |
8,250,000
| – | – | 1.6% | 21 |
|
|
2015
Q4 | $7.4M | Buy |
8,250,000
+5,000,000
| +154% | +$4.49M | 3.11% | 10 |
|
|
2015
Q3 | $2.63M | Buy |
3,250,000
+708,541
| +28% | +$574K | 1.04% | 24 |
|
|
2015
Q2 | $7.65M | Buy |
2,541,459
+1,502,807
| +145% | +$4.52M | 2.98% | 11 |
|
|
2015
Q1 | $2.55M | Buy |
+1,038,652
| New | +$2.55M | 1.12% | 22 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 36 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 42 |
|
|
2014
Q2 | – | Sell |
-193,567
| Closed | -$1.28M | – | 41 |
|
|
2014
Q1 | $1.28M | Buy |
+193,567
| New | +$1.28M | 0.67% | 30 |
|